04.01.22 -- How Genetic Drivers Are Driving New Approaches To Clinical Trials For Rare, Genomically Defined Cancers

Writing a scientific manuscript involves considerable planning and organization to boost your chances of publication in a peer-reviewed journal. Here, we show you how to develop a thorough plan to present research logically and how to avoid the common pitfalls of authorship so you can overcome the chances of rejection for publication.

By allowing the collection of electronic patient reported outcomes (ePROs) by trained personnel during a remote interview, discover how the interview mode constitutes an additional data entry mode when clinical trial participants cannot go to the study site for a scheduled visit.

As clinical trials continue to modernize at pace, there is an urgent need for digital transformation in the industry. If sponsors are to realize their goals of running flexible trials while adopting Big Data, the emphasis must now be placed on technology solutions that optimize clinical trial data workflows.

Read how five Florence employees with clinical research backgrounds came together to craft a checklist designed to walk sites through the process of tech-enabled study start-up.  

This blog describes how effectively involving physicians and site staff during the trial design process can drive efficiencies that may improve recruitment efforts.

Even though the COVID-19 pandemic further exacerbated some of the challenges associated with clinical trials, explore how it fast tracked the adoption of decentralized trials and the consent process, enabling subjects to easily participate remotely.

Discover insight into the importance of — and requirements for — nonclinical studies and review recommendations for putting together a nonclinical program team that optimizes the likelihood of moving candidates into clinical trials.

A Top 10 global biopharmaceutical company needed to implement a single clinical study data review system to reduce the time, cost, and risk of running their clinical trials while accelerating the time-to-market. The company deployed PerkinElmer's interactive data visualization and analysis solution to their clinicians and safety reviewers, which is quickly becoming the tool of choice.

Our objective is to help speed your molecule through early phase trials to prepare you for commercial success. This e-book explains our comprehensive support to help streamline the end-to-end process.

A survey was conducted to understand the adaptations that have been made to clinical trials and their effects. The available research results provide valuable insight into the lasting and positive impact of the adaptions made during the pandemic and reveal an industry embracing change.

This eBook examines the rising trend in compliance findings due to incomplete or poor-quality Trial Master File (TMF) submissions.

Discover how pediatric clinical studies require additional care and considerations in the available infographic.